Placebo with a matching appearance to 100 mg niraparib capsules, filled with an excipient blend for clinical development., NIRAPARIB TOSILATE MONOHYDRATE
PR-30-5017-C
Phase 3 small_molecule active
Quick answer
Placebo with a matching appearance to 100 mg niraparib capsules, filled with an excipient blend for clinical development., NIRAPARIB TOSILATE MONOHYDRATE for Homologous recombination deficiency advanced ovarian cancer is a Phase 3 program (small_molecule) at TESARO Bio Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TESARO Bio Netherlands B.V.
- Indication
- Homologous recombination deficiency advanced ovarian cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active